FDA Restricts Use Of J&J COVID-19 Vaccine Due To Blood Clot Risk

The Food and Drug Administration said the shot should be given only to those who request it or cannot receive other vaccinesUS regulators on Thursday strictly limited who can receive Johnson & Johnson’s Covid-19 vaccine due to a rare but serious risk of blood clots.The
US authorities for months have recommended that Americans starting their Covid-19 vaccinations use the Pfizer or Moderna shots instead.
Source: the guardian

Summary automatically generated by NewSUM A.I. from the following sources:

About the author